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Abstract
Lynch syndrome (LS) leads to an increased risk of early-onset colorectal and other types of cancer and is caused by germline
mutations in DNA mismatch repair (MMR) genes. Loss of MMR function results in a mutator phenotype that likely underlies
its role in tumorigenesis. However, loss of MMR also results in the elimination of a DNA damage-induced checkpoint/
apoptosis activation barrier that may allow damaged cells to grow unchecked. A fundamental question is whether loss of
MMR provides pre-cancerous stem cells an immediate selective advantage in addition to establishing a mutator phenotype.
To test this hypothesis in an in vivo system, we utilized the planarian Schmidtea mediterranea which contains a significant
population of identifiable adult stem cells. We identified a planarian homolog of human MSH2, a MMR gene which is
mutated in 38% of LS cases. The planarian Smed-msh2 is expressed in stem cells and some progeny. We depleted Smed-
msh2 mRNA levels by RNA-interference and found a striking survival advantage in these animals treated with a cytotoxic
DNA alkylating agent compared to control animals. We demonstrated that this tolerance to DNA damage is due to the
survival of mitotically active, MMR-deficient stem cells. Our results suggest that loss of MMR provides an in vivo survival
advantage to the stem cell population in the presence of DNA damage that may have implications for tumorigenesis.
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Introduction
Lynch syndrome (LS), also referred to as hereditary non-polyposis
colorectal cancer, is a hereditary disease that leads to increased risk of
early-onset colorectal and other cancers and is caused by germline
mutations in DNA mismatch repair (MMR) genes [1]. LS is an
autosomal dominant disorder in which the patient inherits one
mutant allele and loses the remaining wild-type copy in the tumor. A
fundamental question is what happens to the cell upon loss of the
remaining wild-type allele such that cancer develops? One hypothesis
is that the resultant loss of MMR function leads to a cell with a
mutator phenotype, accelerating the tumorigenic process [2]. It is not
clear, however, whether this cell, upon loss of MMR function,
acquires a selective advantage prior to developing further mutations
in growth control and survival genes. In addition to repair, the MMR
proteins activate cell cycle checkpoints and apoptosis in response to
DNA damage in tissue culture experiments [3]. Thus, we hypothesize
that the MMR-defective cell in vivo will have a growth and/or
survival advantage over neighboring cells under conditions that give
rise to MMR-sensitive damage.
We are interested in the effects of MMR loss in the adult stem cell in
vivo. Focus on the adult stem cell as the tumor cell of origin has
increased in the past decade [4,5]. To address the effects of MMR loss
in adult stem cells, we examined the planarian Schmidtea mediterranea.
Planarians are bilaterally symmetric metazoan flatworms that contain a
population of pluripotent, proliferative adult stem cells called neoblasts.
Found throughout the body, the neoblasts function to replace cells lost
during normal physiological turnover and upon injury making these
organisms an excellent model for studying genes involved in the early
stages of converting a normal stem cell to a cancerous cell [6,7].
For the purpose of this study, we focused on Smed-msh2 since its
human homolog is commonly mutated in LS [8] and because of its
involvement in damage recognition [9]. We exposed animals
depleted of Smed-msh2 by RNA-interference (RNAi) to a DNA
alkylating agent, a potent inducer of MMR-dependent cell death
in vitro [10], and determined that planarians lacking MMR were
more tolerant to DNA damage than control animals and thus
displayed increased survival. Similarly, we observed improved
animal regeneration and an increased presence of mitotic cells
after DNA damage in Smed-msh2 deficient animals, suggesting that
loss of MMR provides adult stem cells with an in vivo survival
advantage in this cytotoxic environment.
Results
Identification of planarian MMR homologs
The DNA MMR proteins have been extensively studied across
many evolutionarily divergent model organisms. In order to find
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MMR family members in planarians, the human MMR protein
sequences MSH2, MSH6, and MLH1 were used to search the
draft assembly of the S. mediterranea genome [11]. TBLASTN [12]
revealed significant similarities from which we were able to design
gene-specific primers and clone fragments of each gene. 59 and 39
RACE were used to clone full-length cDNA sequences for Smed-
msh2 (GenBank accession number JF511467), Smed-msh6 (GenBank
accession number JF519637), and Smed-mlh1 (GenBank accession
number JF511468), including their respective 59 and 39 UTRs
(Figure 1A). The three MMR genes cluster with other MSH and
MLH homologs phylogenetically (Figure 1B and S1). Gene
ontology annotations [13] predict that Smed-msh2, Smed-msh6 and
Smed-mlh1 contain domains associated with ATP binding,
mismatched DNA binding and MMR. The predicted planarian
Msh2 protein reveals perfect identity at all four adenosine
nucleotide-binding motifs conserved in the MutS family that are
necessary for proper function (Figure 1C).
The distribution of Smed-msh2 expression as determined by whole-
mount in situ hybridization (WISH) is similar to other known
neoblast markers including smedwi-2 [14] and Smed-PCNA [15]. The
expression is primarily posterior to the photoreceptors and excluded
from the highly differentiated pharynx (Figure 2A). We exposed
planarians to gamma irradiation to specifically eliminate neoblasts
and their progeny, leaving post-mitotic tissues unaffected [16,17].
Following irradiation, a dramatic decrease in Smed-msh2 expressing
cells was detected within 24 hours, consistent with expression
localized to the neoblasts (Figure 2A). Weak uniform staining
remained after irradiation suggesting Smed-msh2 is expressed in some
non-neoblasts. We confirmed this by examining Smed-msh2 mRNA
levels from irradiated animals using qRT-PCR. We detected a
,2.5-fold decrease in Smed-msh2 expression one day following
irradiation that remained constant for at least 7 days post irradiation
(Figure 2B). Though the timing of Smed-msh2 expression loss was
similar to Smed-PCNA, the extent of the loss was not as dramatic.
Our findings were further validated using RNA-Seq data generated
from RNA isolated from non-irradiated (NIR) and irradiated (IR)
sexual and asexual animals. We found that expression levels of Smed-
msh2 and Smed-PCNA mRNA decreased in both strains following
irradiation (Figure 2C). Moreover, RNA-Seq data from FACS
purified irradiation-sensitive proliferating neoblasts (X1), irradia-
tion-sensitive non-proliferating neoblasts (X2) and irradiation
insensitive differentiated cells (Xins) revealed that Smed-msh2 and
Smed-PCNA are enriched in proliferating neoblasts (Figure 2C).
Interestingly, we observed a reduced expression of Smed-Msh2 and
Smed-PCNA in asexual animals compared to sexual animals. Taken
together, these results suggest that Smed-msh2 is predominantly
expressed in the stem cell population, though it is also expressed in
some non-neoblast cell types as well.
Smed-msh2 RNAi
Adult planarians that are fed bacterially-expressing dsRNA
targeted to a gene of interest results in specific mRNA knockdown
that efficiently spreads to all tissues throughout the organism [18].
Following RNAi feedings, WISH and qRT-PCR confirmed that
Smed-msh2 was efficiently reduced (Figures 3A and 3B). Smed-
msh2(RNAi) planarians were monitored for one month following
treatment and did not exhibit any apparent phenotypes that
differed from empty-vector fed RNAi [ev(RNAi)] or gfp(RNAi)
controls suggesting that Smed-msh2 is not required for normal tissue
homeostasis. To examine whether loss of Smed-msh2 had an effect
on neoblasts, we bisected the Smed-msh2(RNAi) animals and
monitored regeneration. Upon amputation, planarians are able
to completely regenerate within 17 days in a process that is
dependent on functioning adult stem cells [7,19]. We observed
that Smed-msh2(RNAi) animals regenerated completely similar to
controls. These results were not surprising as constitutive loss of
Msh2 in mice results in live animals that appear to develop
normally [20]. However, these mice succumb to cancer at around
six months of age. To determine the long-term effects of loss of
Smed-msh2 on planarians, we continued weekly Smed-msh2(RNAi) or
ev(RNAi) feedings on small groups of animals and monitored the
animals for an additional three months. At approximately seven
and ten weeks following initial RNAi feeding, we bisected the
animals to determine any regeneration defects. All amputated
fragments from Smed-msh2(RNAi) and ev(RNAi) groups regenerated
completely within two weeks at both time points. After the second
round of regeneration, the control animals resumed normal
growth, but the Smed-msh2(RNAi) animals appeared to shrink. By
the end of the fourth month, two of the Smed-msh2(RNAi) animals
died. The remaining Smed-msh2(RNAi) animals were significantly
smaller than the ev(RNAi) control animals (Figure 3C). These
remaining Smed-msh2(RNAi) animals died shortly after by lysis,
similar to animals treated with gamma-irradiation. We observed a
similar shrinking phenotype with a second group of Smed-
msh2(RNAi) animals that were fed weekly for three months
following injection with DMSO (as a negative control for
experiments described below). These animals were never cut,
however, the Smed-msh2(RNAi) animals shrunk considerably
compared to the ev(RNAi) control animals (Figure 3D).
Effect of DNA damage on Smed-msh2(RNAi) animals
MMR-deficient tumor cell lines and mouse embryonic fibro-
blasts (MEFs) from Msh2, Mlh1 and Msh6 knockout mice are less
sensitive to treatment with the DNA alkylating agent N-methyl-N’-
nitro-N-nitrosoguanidine (MNNG) [10,21,22,23,24,25]. Based on
this in vitro data from higher organisms, we predicted that loss of
Smed-msh2 would result in an increased survival advantage in
planarians treated with MNNG. To test the effects of alkylation
damage on planarians, animals were depleted of Smed-msh2 as
described above. 24 hours after final RNAi feeding, the animals
were injected with varying doses of MNNG or a DMSO-only
control and monitored for the next 24 days (Figure 4A). At the
lowest dose of MNNG (0.4 mg/g) 100% of control and Smed-
msh2(RNAi) animals survived the duration of the experiment.
However, after exposure to 1.0 mg/g MNNG, a significant
survival advantage was observed for the Smed-msh2(RNAi) animals
compared to the gfp(RNAi) animals (P = 0.024, log rank test)
(Figure 4B). Similarly, at the highest dose of MNNG (2.0 mg/g),
100% of the gfp(RNAi) animals died by day 16 while the Smed-
msh2(RNAi) animals showed an overall increase in survival with a
marked delay in death among the animals that did succumb to the
drug (P = 0.0007, log rank test).
MNNG treatment results in the addition of methyl groups to
multiple nucleophilic sites on DNA bases including the O6 position
of guanine. If left unrepaired, the O6-MeG will mismatch with
thymine during DNA replication [26]. The cytotoxicity of O6-
MeG:T mismatches depends upon their recognition by MSH2-
MSH6. To confirm that our Smed-msh2(RNAi) animals are more
resistant to MNNG due to a MMR-dependent recognition of O6-
MeG lesions, we treated these animals with another DNA
alkylating agent, methylmethane sulfonate (MMS). MMS gener-
ates a significantly smaller percentage of O6-MeG lesions than
MNNG, thus its cytotoxicity does not depend upon recognition by
MSH2-MSH6 [26]. Smed-msh2(RNAi) and gfp(RNAi) animals were
treated with increasing doses of MMS and monitored for ten days
after treatment. In contrast with MNNG, there was no survival
advantage observed for Smed-msh2(RNAi) animals compared to
gfp(RNAi) controls (Figure S2). There was a modest survival
Mismatch Repair Defective Stem Cells in Planarians
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Figure 1. The planarian mismatch repair homologs. (A) Exon/intron map of the Smed-msh2, Smed-msh6, and Smed-mlh1 genes. The exons are
depicted by rectangles (ORF= shaded; UTRs = unshaded). Contig numbers are from the S. mediterranea Genome Database (18). Smed-mlh1 spans two
non-overlapping contigs. (B) Phylogenetic trees depicting the evolutionary relationship among the full-length MMR proteins encoded in genomes of
Mismatch Repair Defective Stem Cells in Planarians
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disadvantage for Smed2-msh2(RNAi) animals at the intermediate
dose (500 mM) of MMS that was significant (P = 0.015, log rank
test). These results combined with the MNNG survival data are
consistent with a mechanism in which the Smed-msh2 protein is
involved in an O6-MeG-dependent cell death process.
In order to determine whether the observed survival advantage
following MNNG treatment was the result of a stem-cell specific
response, we took advantage of the regenerative capabilities of the
planarian. To measure stem cell function, we examined the effects
of alkylation damage on regeneration in RNAi treated animals.
Following RNAi feedings as described above, planarians were
injected with 1.0 mg/g MNNG and bisected laterally 24 hours
later (Figure 5A). As a marker for regeneration, we monitored
photoreceptor developments in regenerating tail blastemas.
Regeneration of the photoreceptors occurred by day 5 in 100%
of mock injected gfp(RNAi) and Smed-msh2(RNAi) animals
(Figure 5B). We observed a dramatic inhibition of regeneration
in gfp(RNAi) animals injected with MNNG. Only one animal had
regenerated photoreceptors by day 5, with half of the animals
failing to regenerate at all. Though slightly delayed, all of the Smed-
msh2(RNAi) animals injected with MNNG regenerated photore-
ceptors. These results suggest that loss of Smed-msh2 provides the
stem cells a survival advantage in the presence of DNA damage.
To further confirm that MNNG resulted in the elimination of
the dividing stem cells, we utilized the presence of phosphorylated
histone H3 (pH 3) as a marker for mitotically active cells. Histone
Figure 2. Smed-msh2 expression in neoblasts. (A) Whole-mount in situ hybridization depicting the expression pattern of Smed-msh2 in
planarians. Anterior end at top. Scale bars: 0.5 mm. (B) The expression levels of Smed-msh2 and Smed-PCNA mRNA examined by qRT-PCR using RNA
isolated from five unirradiated or c-irradiated asexual animals. Error bars indicate SD from three experiments. The y-axis fold change is normalized to
Smed-GAPDH. (C) Transcript expression profiles of non-irradiated (NIR) and irradiated (IR) sexual or asexual strains (columns 1-4) and adult cell
populations (columns 5-7, see text for definitions). Raw expression levels (FPKM) were standardized and converted into Z-scores which measure the
number of standard deviations of each value above or below the mean. The color range for Z-scores is indicated in yellow and blue, respectively.
doi:10.1371/journal.pone.0021808.g002
common model organisms using the Neighbor joining method. (C) Alignment of the ATPase domain of several MSH2 family members, with
homologous residues shaded in gray.
doi:10.1371/journal.pone.0021808.g001
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H3 is phosphorylated on its amino terminus as cells traverse from
the G2 to M phase of the cell cycle [27]. Both gfp(RNAi) and Smed-
msh2(RNAi) animals were exposed to MNNG and then fixed 1, 4
or 7 days later. We observed a dramatic decrease in the number of
pH 3-positive cells following MNNG treatment in both groups of
animals. However, we consistently noticed a significantly greater
number of pH 3 stained cells in the Smed-msh2(RNAi) animals at
each time point (p,0.05) (Figures 6A and 6B). These results
suggest that MMR-defective cells are less sensitive to growth arrest
and cell death effects of alkylation damage in vivo.
Discussion
When the MMR genes were first linked to Lynch syndrome, it
was proposed that loss of MMR results in a cell with a mutator
phenotype that accumulates mutations in important oncogenes
Figure 3. Long-term depletion of Smed-msh2 by RNAi leads to shrinkage of animals. (A) WISH of Smed-msh2 in gfp(RNAi) or Smed-
msh2(RNAi) planarians. Dorsal view with anterior end at top. Scale bar: 0.5 mm. (B) qRT-PCR of gfp(RNAi) and Smed-msh2(RNAi) animals. Expression
analyzed seven days after the final RNAi feeding. The y-axis fold change normalized to smed-GAPDH. Error bars indicate SD from samples in triplicate.
(C). Four planarians per group were initially fed Smed-msh2(RNAi) or ev(RNAi) as described under Methods. Animals were fed at weekly intervals
beginning at one month following first feeding. Animals were bisected at seven weeks and again at ten weeks. After four months, animals were
photographed and measured using ImageJ software. (D). Ten planarians per group were initially fed Smed-msh2(RNAi) or ev(RNAi) as described under
Methods then injected with DMSO on day six after the first feeding. Animals were fed at weekly intervals beginning at five weeks following first
feeding. One ev(RNAi) and three Smed-msh2(RNAi) animals died for reasons unrelated to treatment. Additional animals were randomly removed for
verification of RNAi knockdown. After three months, remaining animals were photographed and measured using ImageJ software. Statistical
differences are measured by Student’s t-test (*indicates p,0.05).
doi:10.1371/journal.pone.0021808.g003
Figure 4. Depletion of Smed-msh2 confers tolerance to DNA damage. (A) Experimental timeline for MNNG survival experiments. (B) Survival
curves of gfp(RNAi) and Smed-msh2(RNAi) planarians in response to indicated doses of MNNG generated using GraphPad Prism 5. n = 10 worms per
group. Differences between gfp(RNAi) and Smed-msh2(RNAi) curves are significant for 1.0 mg/g and 2.0 mg/g doses (P = 0.024 and 0.0007,
respectively, using log-rank test).
doi:10.1371/journal.pone.0021808.g004
Mismatch Repair Defective Stem Cells in Planarians
PLoS ONE | www.plosone.org 5 July 2011 | Volume 6 | Issue 7 | e21808
and tumor suppressors at an increased rate [2]. However, the
ability of the MMR proteins to invoke cell cycle checkpoints and
cell death in response to certain DNA lesions indicate that this
pathway may be involved in a more global DNA damage response
that prevents the propagation of cells with damaged DNA. This
global damage response has been proposed to serve as a barrier
against genetic instability that must be overcome for the cell to
progress to malignancy [28,29].
Though much has been learned about MMR function in cell
culture models, to understand the role of MMR in tumorigenesis,
in vivo studies are necessary. Animal models of MMR deficiency
including mouse models have been very useful in this regard [20].
In particular, two mouse models that carry missense mutations in
Msh2 or Msh6 have provided some interesting clues about the role
of the MMR-dependent damage response in tumorigenesis
[30,31]. Mouse embryonic fibroblasts carrying these mutations
were shown to be inefficient at repairing DNA mismatches, yet
maintain the MMR-dependent sensitivity to certain cytotoxic
agents. Interestingly, though these mice develop cancer, the onset
of tumor formation appears significantly delayed compared to
complete gene knockout mice. These results suggest that, though
the establishment of a mutator phenotype is likely the main driving
force for tumorigenesis in MMR-defective cells, the ability of the
MMR proteins to maintain a global DNA damage response may
also play a role in delaying tumorigenesis.
We have previously hypothesized that loss of MMR function in
an adult stem cell may provide a temporary competitive advantage
allowing for the increased propagation of daughter cells that carry a
mutator phenotype [32]. To address this hypothesis, we wanted to
examine the response of MMR-deficient cells to stress prior to
tumor formation. We utilized the planarian S. mediterranea as an in
vivo animal model due to the relative ease with which one can
monitor a population of adult stem cells in this organism. Smed-
msh2(RNAi) animals display increased tolerance to the cytotoxic
effects of the DNA damaging drug MNNG compared to control
animals. In addition, we observed a delayed, but otherwise normal,
regeneration response in Smed-msh2(RNAi) animals exposed to
MNNG compared to gfp(RNAi) controls. Our pH 3 foci studies also
revealed that MMR-defective neoblasts are significantly more
resistant to the effects of DNA damage than normal stem cells. We
did observe an overall decrease in pH 3-positive cells in both the
Smed-msh2(RNAi) and gfp(RNAi) animals after MNNG treatment.
This result likely reflects the ability of MNNG to activate MMR-
independent checkpoint and cell death pathways, possibly through
activation of the base excision repair pathway [33]. An increase in
mitotic activity over time is observed in both populations of animals
suggesting not all of the neoblasts are destroyed by the damage,
however, the increase is significantly greater in the Smed-msh2(RNAi)
group at every time point. It is possible that the differences we
observe would be more dramatic if loss of MMR expression were
complete such as through deactivating mutations. The ability to
generate transgenic planarians would greatly enhance these studies.
A prediction from our results is that the surviving stem cells in the
Smed-msh2(RNAi) animals would continue to accumulate mutations
perhaps leading to tumor formation. There is evidence to suggest
that planarians can develop tumors when treated with carcinogens
[34]. We examined a population of Smed-msh2(RNAi) animals for four
months for signs of tumor formation. We did not observe any
noticeable signs of tumor growth, however, interestingly the Smed-
msh2(RNAi) animals became increasingly smaller compared to
ev(RNAi) control animals. These results may be a phenomenon
limited to the planarian. Planarians are capable of regulating
Figure 5. Smed-msh2-dependent regeneration defect in MNNG treated planarians. (A) Experimental timeline for analyzing regeneration of
gfp(RNAi) and Smed-msh2(RNAi) planarians following MNNG treatment. (B) Percentage of animals with complete regeneration of two photoreceptors
on dorsal fragment following bisection of mock (left panel) or 1.0 mg/g MNNG (right panel) treated animals. White bars: gfp(RNAi). Black bars: Smed-
msh2(RNAi). (n = 10 worms/group)
doi:10.1371/journal.pone.0021808.g005
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neoblast division in response to its environment. When nutrients are
scarce, for example, planarians will shrink due to a change in cell
number [35]. This may result from an increase in apoptosis or
possibly a loss of stem cell asymmetric division in which both
daughters become post-mitotically differentiated cells. We are
currently examining these possibilities in long-term Smed-msh2(RNAi)
fed animals. This ability to regulate total cell number may provide an
extra anti-tumorigenic protection in this organism. Alternatively,
these results may suggest that while loss of MMR can provide a
short-term selective advantage under certain environmental condi-
tions, loss of MMR in the long term is disadvantageous.
Methods
Planarian culturing
Asexual and sexual strains of S. mediterranea were maintained
essentially as described [36] at 20uC in ddH2O supplemented with
1.6 mM NaCl, 1.0 mM CaCl2, 1.0 mM MgSO44, 0.1 mM
MgCl2, 0.1 mM KCl, and 1.2 mM NaHCO3 and fed homoge-
nized calf liver. All animals were starved for one week prior to any
experiments.
Cloning mismatch repair genes
Putative MMR genes were identified by performing TBLASTN
searches of the version 3.1 draft assembly of the S. mediterranea
genome with human MMR proteins. The Smed-msh2, Smed-mlh1,
and Smed-msh6 cDNAs were obtained by RT-PCR cloning of an
internal fragment, followed by 59 and 39 Rapid Amplification of
cDNA Ends using the FirstChoice RLM-RACE kit (Ambion, Inc.).
Gene Expression Analysis
Expression profiles for MMR genes were analyzed using RNA-
Seq data to be described elsewhere (A.M.R., D. P. and B.R.G., in
preparation). Briefly, reads were aligned to the draft assembly of
the S. mediterranea genome using Bowtie alignment software [37].
Read densities were used to measure transcript expression levels in
units of FPKM (fragments per kilobase of exon model per million
mapped reads) [38]. X1, X2 and Xins cell populations were
isolated from sexual planarians by fluorescent activated cell sorting
as previously described [39]. Transcript expression levels between
irradiated and non-irradiated samples and X1, X2 and Xins cell
populations were compared using Z-scores.
RNAi
cDNAs for individual genes were cloned into pDONRdT7 [40]
using a BP reaction (Invitrogen) and the resulting clones
transformed into Escherichia coli strain HT115. 2.0 mL of bacterial
culture was pelleted and resuspended in 25 mL of 1:1 homogenized
calf liver and water, and mixed with 0.7 mL of red food coloring to
form a paste. Animals were fed RNAi every other day for a total of
three feedings. For long-term RNAi experiments, animals were
initially fed as described above, then fed once per week for the
duration of the experiment.
Quantitative Reverse Transcriptase PCR
First strand cDNA was synthesized from 2 mg of total planarian
RNA using SuperScriptII (Invitrogen). Total RNA was DNase I
(Amp Grade, Invitrogen) treated prior to reverse transcription.
Gene specific primers were designed for the individual candidate
genes using the Custom TaqManH Assay Design Tool (Applied
Biosystems). All qRT-PCR experiments were performed in
triplicate using an Applied Biosystems StepOneTM Real-Time
PCR system. For RNAi experiments, the Standard Curve Method
was used to determine the level of gene expression, using the
ubiquitously expressed Smed-GAPDH (H.8.10b) as a reference. For
irradiation experiments, planarians were exposed to 90 Gy of c-
irradiation using a Gamma Cell 1000 Cesium 137 irradiator at
,200 rad/min for 45 min. The Comparative DDCt Method was
used to determine gene expression levels of Smed-msh2 and Smed-
PCNA.
Survival and Regeneration Assays
RNAi was performed on groups of ten sexual animals [41]. One
day following the last RNAi feeding (as described above), animals
were injected once with the indicated concentrations of MNNG
(obtained from the National Cancer Institute Chemical Carcin-
ogen Reference Standard Repository; CAS: 70-25-7) dissolved in
DMSO mixed with red food coloring. For the survival assay,
animals were monitored for viability for 24 days following
injection. Alternatively, RNAi treated animals were soaked in
the indicated concentrations of MMS (Sigma) for ten days and
monitored daily for viability. For regeneration assays, animals
Figure 6. Smed-msh2 depletion enhances survival of mitotically
active neoblasts in MNNG treated planarians. The number of
H3ser10 p (pH 3) stained foci per mm2 as a marker of mitotically active
neoblasts in mock (A) and MNNG (B) treated planarians. gfp(RNAi) and
Smed-msh2(RNAi) animals were stained following exposure to 1.0 mg/g
MNNG at days 1, 4, and 7-post injection. White bars: gfp(RNAi). Black bars:
Smed-msh2(RNAi). Statistical differences measured by Student’s
>test and error bars indicate SEM.<?FIGTITLE 0 (* indicates p,0.05) n=at
least four animals per experiment with two experimental replicates. (C)
Representative animals from day four time point. Dorsal view with anterior
end at top. * indicates location of photoreceptors. Scale bars: 200 mm.
doi:10.1371/journal.pone.0021808.g006
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were bisected laterally 24 hours after 1.0 mg/g MNNG or vehicle
control injection and tail fragments were monitored for appear-
ance of both photoreceptors.
Immunohistochemistry and whole-mount in situ
hybridization (WISH)
Immunostaining with anti-phosphohistone H3 (pH 3) antibody
(Cell Signaling) was performed as described [40]. Specimens were
imaged on a Zeiss LSM 510Meta confocal microscope. Images
were processed and quantified using ImageJ (http://rsbweb.nih.
gov/ij/). WISH was performed essentially as described [42].
Hybridization was carried out at 55uC in prehybridization buffer
supplemented with 2% dextran sulfate. Animals were developed
using BM Purple (Roche).
Supporting Information
Figure S1 Smed-Msh2 clusters with other MSH2 homo-
logs. Phylogenetic tree depicting the evolutionary relationship
among the full-length MutS protein homologs encoded in
genomes of common model organisms using the Neighbor joining
method.
(TIF)
Figure S2 Depletion of Smed-msh2 confers no selective
advantage to MMS. Survival curves of gfp(RNAi) and Smed-
msh2(RNAi) planarians in response to indicated doses of MMS
generated using GraphPad Prism 5. n = 10 worms per group.
Differences between gfp(RNAi) and Smed-msh2(RNAi) curves are
significant for 500 mM MMS curves (P = 0.015, using log-rank
test).
(TIF)
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